FDA Approves Revuforj® as First Menin Inhibitor for Acute Leukemia with KMT2A Translocation

CHMP Recommends Approval of Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H/dMMR Metastatic Colorectal Cancer

ADDF Invests $1.18M to Standardize p-tau217 Blood Tests for Alzheimer’s Diagnosis

GSK Reports Positive Interim Results for DREAMM-7 Trial of Blenrep in Multiple Myeloma

Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Home
/
insight
/
details

Transforming Precision Medicine: The Rise of Nanoparticles in Healthcare

NextEdge Admin

21 Jan 2024

3 min 49 sec

In the ever-evolving field of Nano medicine, scientists are making ground-breaking strides in developing tiny particles to deliver drugs effectively. These nanoparticles are becoming crucial tools in treating various diseases, and since 2016, significant progress has been made.

Imagine these nanoparticles as tiny vehicles carrying medicine directly to specific areas in the body. This is particularly important because it enhances the effectiveness of treatments while minimizing side effects. In a 2016 review, over 25 such Nano medicines had received approval from regulatory agencies like the FDA or were being evaluated in clinical trials.

Fast forward to 2019, and there are now even more exciting developments. Three new Nano medicines have received approval. One of them, VYXEOS, is a nanoscale combination chemotherapy that’s proven highly effective against a type of leukaemia. Not only does it improve overall survival, but it also allows for a lower dose of the drugs compared to traditional methods, potentially reducing side effects.

Another breakthrough is Patisiran, a lipid-based nanoparticle developed for treating a hereditary condition causing abnormal protein build-up. Patisiran represents the first FDA-approved example of a therapy using RNA interference (RNAi), a sophisticated mechanism to “silence” specific genes. This is a major milestone in the biotech industry, demonstrating how nanotechnology can enable the delivery of complex therapies.

These advancements highlight the potential of Nano medicine in revolutionizing how we approach disease treatment. The nanoparticles act as carriers, delivering therapies with precision and efficiency. For example, VYXEOS delivers a combination of drugs in a synergistic ratio, enhancing their impact on target cells. This is a departure from traditional drug delivery where different drugs may have distinct effects and metabolism rates.

The significance of these developments extends beyond their immediate applications. They pave the way for future innovations in drug combinations and sophisticated therapies. Patisiran’s success, in particular, opens doors for more RNAi therapies, marking a new era in medicine.

In addition to these approved Nano medicines, numerous clinical trials are underway, exploring the potential of other nanoparticles in treating various conditions. The hope is that these tiny particles will play a significant role in the future of medicine, offering more effective treatments with fewer side effects. As we witness these advancements, it becomes clear that Nano medicine is not just a buzzword but a transformative force in healthcare.